Skip to main content

Table 2 Unadjusted outcomes of obstetric patients with a PcnA label versus patients without a PcnA label

From: Outcomes in reported penicillin allergic mothers and neonates requiring Group B streptococcal prophylaxis: a retrospective observational cohort study

 

PcnA label

No PcnA label

p-value

Number of patients, n (%)

506 (11.5%)

3881 (88.5%)

 

Primary Maternal Outcomes

 Hospital LOS in days, median (IQR)

2.13 (1.74—2.44)

2.06 (1.69—2.36)

*0.01

Secondary Maternal Outcomes

 Total cost of care, dollars, median (IQR)

6796 (5344—8839)

6444 (5023—8489)

*0.004

 Days of antibiotic use, mean (SD)

1.3 (0.6)

2.7 (4.5)

* < 0.001

 30-day readmission, ED and IP, n (%)

20 (4.0%)

205 (5.3%)

0.26

 PICC line use, n (%)

19 (3.8%)

0 (0.0%)

* < 0.001

 ICU admission, n (%)

0 (0.0%)

4 (0.1%)

 > 0.99

 Pregnancy at ICU admission, n (%)

0 (0.0%)

1 (25%)

NA

Primary Neonatal Outcomes

 Baby LOS > 48 h, yes, n (%)

133 (26.0%)

831 (21.2%)

*0.01

Secondary Neonatal Outcomes

 Level 2 nursery, n (%)

62 (12.1%)

494 (12.6%)

0.74

 Birth outcome, n (%)

  

 > 0.99

  Live birth

512 (100%)

3908 (99.9%)

 

  Fetal death or miscarriage

0 (0.0%)

6 (0.2%)

 
  1. *Statistical significance was set at p < 0.05. ED emergency department, ICU intensive care unit, IP inpatient, IQR interquartile range, LOS length of stay, PcnA penicillin allergy, PICC peripherally inserted central catheter, SD standard deviation